Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC): CheckMate 9DW Asian subgroup analysis Yau, T.; Galle, P. R.; Decaens, T.; Sangro, B.; Qin, S.; Park, J-W.; Ikeda, M.; Tai, D. W. M.; Chiu, C-F.; Chon, H. J.; Kang, Y-K.; Hiraoka, A.; Huang, Y-H.; Lee, T-Y.; Numata, K.; Yamashita, T.; Ogata, T.; Hreiki, J.; Lu, Y.; Kudo, M. Share Save
Enhanced versus standard hydration in acute ischemic stroke: REVIVE-A randomized clinical trial Lin, Leng Chieh; Lee, Tsong-Hai; Huang, Yen Chu; Tsai, Yuan Hsiung; Yang, Jen Tsung; Yang, Lan Yan; Pan, Yu-Bin; Lee, Meng; Chen, Kuan-Fu; Hung, Yu-Cheng; Cheng, Hsien-Hung; Lee, I-Neng; Lee, Ming Hsueh; Chiu, Tefa; Chang, Yeu-Jhy; Goh, Zhong Ning Leonard; Seak, Chen-June Share Save
Perfusion Profiles May Differ Between Asymptomatic Versus Symptomatic Internal Carotid Artery Occlusion Chang, Ting -Yu; Christensen, Soren; Mlynash, Michael; Heit, Jeremy J.; Marks, Michael P.; Lee, Sarah; McCullough-Hicks, Margy E.; Ostojic, Lili Velickovic; Kemp, Stephanie; Albers, Gregory W.; Srivatsan, Aditya; Lee, Tsong-Hai; Lansberg, Maarten G. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save